Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial
Benjamin Z. Galper(Atlantic General Hospital), Michael J. Mack(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Susheel Kodali(Columbia University Irving Medical Center), John G. Webb(St. Paul's Hospital), Raj Makkar(Cedars-Sinai Medical Center), Khaja Chinnakondepalli(Saint Luke's Hospital), Howard C. Herrmann(University of Pennsylvania), Mathew Williams(Mount Sinai Health System), Elizabeth A. Magnuson(Saint Luke's Health System), Samir Kapadia(Cleveland Clinic), David J. Cohen(Baim Institute for Clinical Research), Kaijun Wang(Saint Luke's Hospital), Michael Lu(Children's Hospital of Los Angeles), Martin B. Leon(Columbia University Irving Medical Center), Vinod H. Thourani(Valve (United States)), Craig R. Smith(University of Arizona)
Cited by 39
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k